Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Directors Deals Ltd.
$12.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

VITA 34 AG to Cooperate with Bio Save and to Enter Romanian and Croatian Markets


Monday, 8 Jul 2013 03:53am EDT 

VITA 34 AG announced that it plans to expand its international presence by means of cooperative ventures with the Serbian Bio Save company. Bio Save plans on expanding activities to Romania and Croatia. Thanks to the existing, nearly year-old sales and marketing cooperative venture with Bio Save, Vita 34 is storing umbilical cord blood for customers from Serbia, Montenegro, Macedonia and Bosnia-Herzegovina. Vita 34 expects positive impetus on the number of storages from the planned Bio Save expansion. Moreover, Vita 34 will round out its offering in the East European market with an additional cooperation partner in Bulgaria. Apart from Germany, Vita 34 is active in a total of eleven European countries via subsidiaries and cooperation partners. 

Company Quote

3.867
-0.032 -0.82%
15 Aug 2014